Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.9%

1 terminated/withdrawn out of 35 trials

Success Rate

94.1%

+7.6% vs industry average

Late-Stage Pipeline

17%

6 trials in Phase 3/4

Results Transparency

0%

0 of 16 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
12(44.4%)
Phase 1
6(22.2%)
Phase 2
3(11.1%)
Phase 3
3(11.1%)
Phase 4
3(11.1%)
27Total
N/A(12)
Phase 1(6)
Phase 2(3)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (35)

Showing 20 of 35 trials
NCT03331718Phase 3Completed

PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial)

Role: collaborator

NCT06983210Phase 2Recruiting

Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma

Role: lead

NCT05863234Phase 1Recruiting

Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia

Role: collaborator

NCT03413592Not ApplicableCompleted

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #2

Role: collaborator

NCT03278080Not ApplicableCompleted

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1

Role: collaborator

NCT04108351Not ApplicableCompleted

Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control

Role: collaborator

NCT03572985Not ApplicableCompleted

Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3

Role: collaborator

NCT06481358Active Not Recruiting

Deep Learning-based Artificial Intelligence for the Diagnosis of Small Bowel Obstruction

Role: lead

NCT05064618Phase 1Recruiting

Investigator-initiated Clinical Trial of MIKE-1

Role: lead

NCT03055481Not ApplicableTerminated

A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice

Role: lead

NCT04261335Phase 1Completed

The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy

Role: lead

NCT04342325Phase 1Completed

The Clinical Trial of ADR-001 for IgA Nephropathy

Role: lead

NCT04052243Not ApplicableUnknown

Hemodynamic Effects of BPA at Rest and During Exercise in CTEPH

Role: collaborator

NCT02616705Completed

Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis

Role: collaborator

NCT03864185Phase 2Completed

The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies

Role: lead

NCT02717091Phase 2Unknown

Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer

Role: lead

NCT02529865Phase 3Completed

Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence

Role: lead

NCT02256618Phase 1Completed

Autologous Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT02455830Unknown

Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy

Role: collaborator

NCT01261234Not ApplicableCompleted

Carotid Artery Stenting With Cilostazol Addition for Restenosis

Role: collaborator